|
| Friday, 5 November 2021, 22:08 HKT/SGT | |
| |  | |
Source: CrowdEngine | |
|
|
|
SALT LAKE CITY, UT, Nov 5, 2021 - (ACN Newswire) - CrowdEngine, the leading private-label JOBS Act investment crowdfunding platform, announced it's launching a new customization service so CRE firms can have a custom investment website with personalized dashboards and brand specific front-ends. In addition, CRE firms will also benefit from CrowdEngine's ability to support capital raises under any U.S. regulations, including Reg. D, Reg. S, Reg. A, and Reg CF.
"Offering investors online dashboards and reports, as well as being able to raise capital online, has become a 'must' for CRE firms who want to stay competitive in light of the pandemic, but current solutions are not customizable, so we've launched a CRE specific solution to take advantage of our unmatched customization capabilities and proven fundraising technology," said Jim Borzilleri, CEO of CrowdEngine.
"Unlike other investor management software, CrowdEngine clients can customize 98% of the front-end, or if you don't have those capabilities, we can do it for you - and if you need specific reporting or dashboards, we can do that too," said Justin Turner, CTO. CrowdEngine can also build custom integrations with HubSpot, Salesforce, or most other CRMs so clients can have a single "source of truth" for all their investor sales and marketing data.
CrowdEngine also offers the Compliance Engine, the most advanced investment technology on the market that has been used by 100's of clients to date. Its ability to support multiple offering types under any U.S. regulation is supported by the ability for investors to invest using multiple profiles, so they can invest personally, or use any LLC or entity.
By leveraging this new offering, CRE firms will be able to avoid a common "cookie-cutter" website with a completely custom design, custom dashboards, and be able to raise capital using any U.S. regulation faster and at a fraction of the cost of building themselves.
"Focusing on the $16 trillion commercial real estate market is an exciting growth opportunity for the company," said Boon Saysavanh, Vice-President of Sales. "This will help us expand the benefits of our core technology into a new market that is just beginning to modernize their processes."
Companies interested in learning more can find more information here http://www.crowdengine.com/real-estate
About CrowdEngine
CrowdEngine was founded in 2013 to provide JOBS Act crowdfunding software and has worked with 100's of clients. Our proprietary Compliance Engine technology enables our clients to launch their own investor management and fundraising website that supports all offering types in the U.S. including Reg. D, Reg. S, Reg. A+, and Reg. CF. For more information, visit www.crowdengine.com or call us at 888-645-7018.
Source: Plato Data Intelligence: zephyrnet.com (bit.ly/3k6pH1W)
Topic: Press release summary
Source: CrowdEngine
Sectors: Real Estate & REIT, PE, VC & Alternatives
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport
Monday, December 15, 2025 6:41:00 PM
|
|
|
NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz
Monday, December 15, 2025 6:04:00 PM
|
|
|
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
Dec 15, 2025 16:59 HKT/SGT
|
|
|
Indonesia's KAI Launches Farmer-Trader Train, Expands Facial Recognition Tech Ahead of 2025/2026 Holiday Travel Surge 
Dec 15, 2025 13:00 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Monday, December 15, 2025 7:30:00 AM
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Friday, December 12, 2025 10:15:00 PM
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Friday, December 12, 2025 10:00:00 AM
|
|
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
 |
|
 |
|
